Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 101–200 of 931
Disorders of ubiquitylation: unchained inflammation
Beck, D. B., Werner, A. A., Kastner, D. L., & Aksentijevich, I. A. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00778-4 · Cited by 141
Solomon, O., Segni, A. D., Cesarkas, K., Porath, H. T., Marcu‐Malina, V., Mizrahi, O., Stern‐Ginossar, N., Kol, N., Barhom, S. F., Glick‐Saar, E., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01458-8 · Cited by 139
Monogenic lupus: Dissecting heterogeneity
Omarjee, O., Picard, C., Frachette, C., Moreews, M., Rieux‐Laucat, F., Soulas-Sprauel, P., Viel, S., Lega, J., Bader‐Meunier, B., Walzer, T., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102361 · Cited by 138
Heraud-Farlow, J. E., Chalk, A. M., Linder, S. E., Li, Q., Taylor, S., White, J. M., Pang, L., Liddicoat, B., Gupte, A., Li, J. B., et al. (2017) · Genome biology · doi:10.1186/s13059-017-1301-4 · Cited by 126
“Discussion The consequences of altered ADAR1 function are severe, from embryonic lethality in mice to debilitating neurological disease and systemic interferonopathy in humans with loss-of-function alleles [22, 52], to putative oncogenic roles when overexpressed [31, 53, 54], so it is critical to clearly define the ke…”
BackgroundInfluentialIRGM1 links mitochondrial quality control to autoimmunity
Rai, P., Janardhan, K. S., Meacham, J. M., Madenspacher, J. H., Lin, W.-C., Karmaus, P. W. F., Martinez, J., Li, Q., Yan, M., Zeng, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00859-0 · Cited by 134
Evans’ Syndrome: From Diagnosis to Treatment
Audia, S., Grienay, N., Mounier, M., Michel, M., & Bonnotte, B. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123851 · Cited by 147
“In case of SLE-associated ES, the measurement of classical complement pathway activation (CH50, factors C3 and C4) is of interest as a marker of SLE activity.”
BackgroundInfluentialReinert, L. S., Rashidi, A. S., Tran, D. N., Katzilieris-Petras, G., Hvidt, A. K., Gohr, M., Fruhwürth, S., Bodda, C., Thomsen, M. K., Vendelbo, M. H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136824 · Cited by 118
“This is illustrated by the autoinflammatory disease Aicardi1 Goutieres syndrome, which is an encephalopathy driven by IFN-inducing signaling pathways sharing 2 some features with congenital viral infections, including intracranial calcifications (29).”
BackgroundIntegrated classification of inflammatory myopathies
Allenbach, Y., Benvéniste, O., Goebel, H., & Stenzel, W. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12380 · Cited by 123
Structural basis for nucleosome-mediated inhibition of cGAS activity
Cao, D., Han, X., Fan, X., Xu, R.-M., & Zhang, X. (2020) · Cell Research · doi:10.1038/s41422-020-00422-4 · Cited by 133
The pathogenesis of cerebral small vessel disease and vascular cognitive impairment
Markus, H. S., & Joutel, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00028.2024 · Cited by 163
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis
Anders, H., & Rovin, B. H. (2016) · Kidney International · doi:10.1016/j.kint.2016.05.017 · Cited by 135
Nucleases Acting at Stalled Forks: How to Reboot the Replication Program with a Few Shortcuts
Pasero, P., & Vindigni, A. (2017) · Annual Review of Genetics · doi:10.1146/annurev-genet-120116-024745 · Cited by 136
N-glycanase NGLY1 regulates mitochondrial homeostasis and inflammation through NRF1
Yang, K., Huang, R., Fujihira, H., Suzuki, T., & Yan, N. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180783 · Cited by 121
“Unchecked hyperactivation of type I IFN signaling has been described in several monogenic autoimmune and autoinflammatory diseases that are collectively known as type I interferonopathies (Crow and Manel, 2015).”
BackgroundInfluentialSignificance of the cGAS-STING Pathway in Health and Disease
Zhou, J., Zhuang, Z., Li, J., & Feng, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713316 · Cited by 148
“(H) The role of the cGAS–STING pathway in SLE.”
BackgroundInfluentialDiseases of the nERVous system: retrotransposon activity in neurodegenerative disease
Tam, O. H., Ostrow, L. W., & Gale Hammell, M. (2019) · Mobile DNA · doi:10.1186/s13100-019-0176-1 · Cited by 117
Liu, J., Yuan, L., Ruan, Y., Deng, B., Yang, Z., Ren, Y., Li, L., Liu, T., Zhao, H., Mai, R., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01948 · Cited by 122
Negative regulation of type I IFN signaling
Arimoto, K.-I., Miyauchi, S., Stoner, S. A., Fan, J.-B., & Zhang, D.-E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-342r · Cited by 117
Kavanagh, D., McGlasson, S. L., Jury, A., Williams, J., Scolding, N. J., Bellamy, C. O. C., Günther, C., Ritchie, D. L., Gale, D. P., Kanwar, Y. S., et al. (2016) · Blood · doi:10.1182/blood-2016-05-715987 · Cited by 122
“In these disease states, IFN levels are spontaneously elevated in the context of activated innate immunity.(27) As such, they might be considered by the Bradford-Hill criteria to represent an “analogous” systemof human IFN toxicity.”
BackgroundISG15: In Sickness and in Health
Hermann, M., & Bogunovic, D. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.11.001 · Cited by 120
Konno, H., Chinn, I. K., Hong, D., Orange, J. S., Lupski, J. R., Mendoza, A., Pedroza, L. A., & Barber, G. N. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.115 · Cited by 114
“For example, a loss-of-function mutation in the DNase TREX1 (DNaseIII) has been found to cause severe forms of SLE referred to as AicardiGoutières syndrome (AGS) in human patients (Crow and Manel, 2015).”
InfluentialThe majority of A-to-I RNA editing is not required for mammalian homeostasis
Chalk, A. M., Taylor, S., Heraud-Farlow, J. E., & Walkley, C. R. (2019) · Genome biology · doi:10.1186/s13059-019-1873-2 · Cited by 117
Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
Rice, G. I., Park, S., Gavazzi, F., Adang, L. A., Ayuk, L. A., Van Eyck, L., Seabra, L., Barrea, C., Battini, R., Belot, A., et al. (2020) · Human Mutation · doi:10.1002/humu.23975 · Cited by 112
“Consequent to Mendelian determined gain-of-function, it is suggested that IFIH1 inappropriately senses self-derived nucleic acid as viral, leading to an autoinflammatory state classified as a type I interferonopathy (Ahmad et al., 2018; Crow & Manel, 2015).”
BackgroundSelf-citationSex differences in innate and adaptive immunity impact fetal, placental, and maternal health
Baines, K. J., & West, R. C. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad072 · Cited by 129
“More recent work has focused on dysregulated type I IFN signaling, leading to obstetric complications including preeclampsia, preterm birth, and neurocognitive impairments in the offspring [139–141].”
LINE1 contributes to autoimmunity through both RIG-I- and MDA5-mediated RNA sensing pathways
Zhao, K., Du, J., Peng, Y., Li, P., Wang, S., Wang, Y., Hou, J., Kang, J., Zheng, W., Hua, S., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.007 · Cited by 106
Ghosh, A., Shao, L., Sampath, P., Zhao, B., Patel, N. V., Zhu, J., Behl, B., Parise, R. A., Beumer, J. H., O’Sullivan, R. J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.013 · Cited by 111
“Furthermore, cGAS-STING-pathway-mediated IFN induction is important for the development of autoimmune diseases (Crow, 2016; Crow and Manel, 2015; Crowl et al., 2017).”
Physiological functions of RIG-I-like receptors
Yoneyama, M., Kato, H., & Fujita, T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.003 · Cited by 128
Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy
Lin, H., Xiong, W. G., Fu, L., Yi, J., & Yang, J. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00305-3 · Cited by 151
Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1
Maelfait, J., Bridgeman, A., Benlahrech, A., Cursi, C., & Rehwinkel, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.002 · Cited by 109
“AGS patients spontaneously produce IFNs in the absence of infection with exogenous viruses (Crow and Manel, 2015).”
BackgroundInfluentialDing, J., Maxwell, A. J., Adzibolosu, N. K., Hu, A., You, Y., Liao, A., & Mor, G. (2022) · Immunological Reviews · doi:10.1111/imr.13077 · Cited by 130
Bloom syndrome protein restrains innate immune sensing of micronuclei by cGAS
Gratia, M., Rodero, M. P., Conrad, C., Bou Samra, E., Maurin, M., Rice, G. I., Duffy, D., Revy, P., Petit, F., Dale, R. C., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181329 · Cited by 105
Self-citationTreatments in Aicardi–Goutières syndrome
Crow, Y. J., Shetty, J., & Livingston, J. H. (2019) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.14268 · Cited by 115
Self-citationFang, R., Jiang, Q., Jia, X., & Jiang, Z. (2023) · Immunity · doi:10.1016/j.immuni.2023.02.004 · Cited by 102
HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
Lahouassa, H., Blondot, M.-L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B. C., Schwartz, O., & Margottin-Goguet, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600485113 · Cited by 100
“Another example is provided by Aicardi–Goutières syndrome (AGS), in which the overproduction of type I interferon (IFN) is associated with mutations of proteins involved in DNA synthesis and repair, namely SAM domain and HD domain-containing protein 1 (SAMHD1), ribonuclease H2 (RNase H2), and three prime repair exonuc…”
BackgroundJi, Y., Luo, Y., Wu, Y., Sun, Y., Zhao, L., Xue, Z., Sun, M., Wei, X., He, Z., Wu, S. A., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01138-4 · Cited by 110
“…dsDNA, cytosolic self-DNA, originated from either damaged mitochondrial or unstable genome, can also lead to STING activation and the onset of autoimmune diseases in various pathologies, such as Aicardi–Goutieres syndrome, systemic lupus erythematosus and other type I interferonopathies 10,11 .”
Regulating STING in health and disease
Li, Y., Wilson, H. L., & Kiss‐Toth, E. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0159-2 · Cited by 109
“AGS (Aicardi-Goutières Syndrome) is another genetically-based autoimmune disease, characterised by DNA-triggered type I interferonopathy [176] (Figure 5).”
BackgroundReview: Cell Death, Nucleic Acids, and Immunity
Elkon, K. B. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40452 · Cited by 108
““Interferonopathies” are a group of monogenic orphan diseases that affect children and are characterized by a type I IFN gene expression signature in the circulating blood (46).”
BackgroundInnate immunity and tolerance toward mitochondria
Rongvaux, A. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.10.007 · Cited by 98
Adenosine-to-inosine RNA editing in neurological development and disease
Yang, Y., Okada, S., & Sakurai, M. (2021) · RNA Biology · doi:10.1080/15476286.2020.1867797 · Cited by 112
“In contrast, Adar1 E861A mutant mice with concurrent depletion of MDA5 are strikingly normal, including their life spans.”
BackgroundInfluentialGedik, K. C., Lamot, L., Romano, M., Demirkaya, E., Piskin, D., Torreggiani, S., Adang, L. A., Armangué, T., Barchus, K., Cordova, D., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221814 · Cited by 111
Self-citationTherapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies
Hasan, M., & Yan, N. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.008 · Cited by 83
cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model
Xiao, N., Wei, J., Xu, S., Du, H., Huang, M., Zhang, S., Ye, W., Sun, L., & Chen, Q. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.03.001 · Cited by 95
Enhanced cGAS-STING–dependent interferon signaling associated with mutations in ATAD3A
Lepelley, A., Mina, E. D., Nieuwenhove, E. V., Waumans, L., Fraitag, S., Rice, G., Dhir, A., Frémond, M., Rodero, M. P., Seabra, L., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201560 · Cited by 105
Self-citationThe mechanism of STING autoinhibition and activation
Liu, S., Yang, B., Hou, Y., Cui, K., Yang, X., Li, X., Chen, L., Liu, S., Zhang, Z., Jia, Y., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.029 · Cited by 108
Interfaces between cellular responses to DNA damage and cancer immunotherapy
Pilger, D., Seymour, L. W., & Jackson, S. P. (2021) · Genes & Development · doi:10.1101/gad.348314.121 · Cited by 95
“Notably, individuals with mutations in the RNase H2 complex, consisting of RNASEH2A, RNASEH2B, and RNASEH2C, show clinical pathologies that resemble those observed in TREX1 mutated patients, including aberrant type I IFN signaling alongwithAGS and systemic lupus erythematosus.”
BackgroundInfluentialRNA Editing in Pathogenesis of Cancer
Baysal, B. E., Sharma, S., Hashemikhabir, S., & Janga, S. C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0520 · Cited by 113
“AGS is a genetically heterogeneous Mendelian disease caused by mutations in several genes involved in nucleic acid metabolism and is characterized by early onset progressive brain disease, certain skin lesions, glaucoma and, in some cases, features resembling systemic lupus erythematosus (17).”
BackgroundTranslation stress and collided ribosomes are co-activators of cGAS
Wan, L., Juszkiewicz, S., Blears, D., Bajpe, P. K., Han, Z., Faull, P. A., Mitter, R., Stewart, A., Snijders, A. P., Hegde, R. S., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.05.018 · Cited by 101
“Indeed, excessive activation of cGAS by self-DNA released from mitochondria or the nucleus may trigger autoimmunity and is associated with inflammatory diseases such as Aicardi-Goutie`res syndrome (AGS) (Ablasser et al., 2013b; Crow and Manel, 2015; Chen et al., 2016).”
BackgroundSAMHD1: At the Crossroads of Cell Proliferation, Immune Responses, and Virus Restriction
Ballana, E., & Esté, J. A. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.08.002 · Cited by 102
Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics
Banchereau, R., Cepika, A., Banchereau, J., & Pascual, V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052225 · Cited by 121
“Adoption of NGS rapidly expanded the spectrum of these type I IFN–mediated disorders, with the discovery of mutations in genes encoding a wide range of molecules involved in positive and negative regulation of IFN production, including nucleases, nucleic acid sensors, and signaling molecules (Table 1) (74).”
BackgroundGenetic, Phenotypic, and Interferon Biomarker Status in ADAR1-Related Neurological Disease
Rice, G., Kitabayashi, N., Barth, M., Briggs, T. A., Burton, A., Carpanelli, M. L., Cerisola, A., Colson, C., Dale, R. C., Danti, F. R., et al. (2017) · Neuropediatrics · doi:10.1055/s-0037-1601449 · Cited by 97
Self-citationSensing of transposable elements by the antiviral innate immune system
Gázquez-Gutiérrez, A., Witteveldt, J., Heras, S. R., & Macías, S. (2021) · RNA · doi:10.1261/rna.078721.121 · Cited by 109
“Mutations in different genes involved in the metabolism or sensing of nucleic acids can lead to AGS (Crow and Manel 2015; Rice et al. 2020).”
BackgroundCristini, A., Tellier, M., Constantinescu, F., Accalai, C., Albulescu, L. O., Heiringhoff, R., Bery, N., Sordet, O., Murphy, S., & Gromak, N. (2022) · Nature Communications · doi:10.1038/s41467-022-30604-0 · Cited by 93
Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus
Roth, S. H., Danan-Gotthold, M., Ben-Izhak, M., Rechavi, G., Cohen, C. J., Louzoun, Y., & Levanon, E. Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.036 · Cited by 92
“SLE patients usually have creativecommons.org/licenses/by-nc-nd/4.0/). elevated levels of circulating type I IFN and increased expression of both type I and type II IFN-stimulated genes (ISGs) (Chiche et al., 2014; Crow and Manel, 2015; Hagberg and Rönnblom, 2015).”
BackgroundInfluentialHu, Y., Chen, B., Yang, F., Su, Y., Yang, D., Yao, Y., Wang, S., Wu, Y., Tao, L., & Xu, T. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103155 · Cited by 98
Acute microglia ablation induces neurodegeneration in the somatosensory system
Rubino, S. J., Mayo, L., Wimmer, I., Siedler, V., Brunner, F., Hametner, S., Madi, A., Lanser, A., Moreira, T., Donnelly, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05929-4 · Cited by 91
Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome
Klase, Z. A., Khakhina, S., Schneider, A. D. B., Callahan, M. V., Glasspool‐Malone, J., & Malone, R. W. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004877 · Cited by 102
“These findings are similar to those observed with heritable disorders, including cystic leukoencephalopathy without megalencephaly, Aicardi–Goutières syndrome, type 1 interferonopathies, and RNASET2-related leukodystrophy [96,97].”
ResultCutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus
Stannard, J. N., & Kahlenberg, J. M. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000308 · Cited by 87
ADAR1‐mediated RNA editing is required for thymic self‐tolerance and inhibition of autoimmunity
Nakahama, T., Kato, Y., Kim, J. I., Vongpipatana, T., Suzuki, Y., Walkley, C. R., & Kawahara, Y. (2018) · EMBO Reports · doi:10.15252/embr.201846303 · Cited by 89
“The autoimmune disease AGS is caused by mutations in the genes involved in cellular nucleotide metabolism including TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and IFIH1 in addition to ADAR1 [52].”
A Novel System to Categorize the Symptoms of Systemic Lupus Erythematosus
Pisetsky, D. S., Clowse, M. E. B., Criscione‐Schreiber, L. G., & Rogers, J. L. (2019) · Arthritis Care & Research · doi:10.1002/acr.23794 · Cited by 94
“The “interferonopathies,” such as AicardiGoutières syndrome, provide dramatic evidence for the activity of type 1 interferon in the brain (42,43).”
BackgroundType I Interferonopathies in Children: An Overview
d’Angelo, D. M., Filippo, P. D., Breda, L., & Chiarelli, F. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.631329 · Cited by 99
“AGS is a progressive encephalopathy with onset within the first year of life, characterized by basal ganglia calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, and elevated type I IFN levels in the CSF without evidence of any congenital infection (2, 45).”
BackgroundSystemic lupus erythematosus: still a challenge for physicians
Bengtsson, A., & Rönnblom, L. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12529 · Cited by 104
Abnormalities of the type I interferon signaling pathway in lupus autoimmunity
Gallucci, S., Meka, S., & Gamero, A. M. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155633 · Cited by 91
Nucleic Acid Sensors and Programmed Cell Death
Maelfait, J., Liverpool, L., & Rehwinkel, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.11.016 · Cited by 91
Mitochondrial Gene Expression and Beyond—Novel Aspects of Cellular Physiology
Kotrys, A. V., & Szczęsny, R. J. (2019) · Cells · doi:10.3390/cells9010017 · Cited by 88
RNase H2, mutated in Aicardi‐Goutières syndrome, promotes LINE‐1 retrotransposition
Benitez‐Guijarro, M., Lopez‐Ruiz, C., Tarnauskaitė, Ž., Murina, O., Mian Mohammad, M., Williams, T. C., Fluteau, A., Sanchez, L., Vilar‐Astasio, R., Garcia‐Canadas, M., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798506 · Cited by 79
“AGS is a type I interferonopathy where aberrant innate immune activation causes type I IFN production and clinical features reminiscent of a congenital viral infection of the brain (Crow & Manel, 2015).”
L1 retrotransposition in the soma: a field jumping ahead
Faulkner, G. J., & Billon, V. (2018) · Mobile DNA · doi:10.1186/s13100-018-0128-1 · Cited by 79
Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity
Peschke, K., Achleitner, M., Frenzel, K., Gerbaulet, A., Ada, S. R., Zeller, N., Lienenklaus, S., Lesche, M., Poulet, C., Naumann, R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600722 · Cited by 79
“IFN, and these conditions were summarized as type I interferonopathies (3).”
BackgroundThe stress granule protein G3BP1 promotes pre‐condensation of cGAS to allow rapid responses to DNA
Zhao, M., Xia, T., Xing, J., Yin, L.-H., Li, X., Pan, J., Liu, J., Sun, L., Wang, M., Li, T., et al. (2021) · EMBO Reports · doi:10.15252/embr.202153166 · Cited by 84
“The chronical activation of cGAS by such self-DNA is a major cause for several autoimmune diseases, such as lupus and Aicardi – Gouti (cid:1) eres syndrome (AGS; Aicardi & Goutieres, 1984; Ahn & Barber, 2014; Lisnevskaia et al , 2014; Crow & Manel, 2015).”
Exosomal biomarkers in Down syndrome and Alzheimer's disease
Hamlett, E. D., Ledreux, A., Potter, H., Chial, H. J., Patterson, D., Espinosa, J. M., Bettcher, B. M., & Granholm, A.-C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.028 · Cited by 76
“First, hyperactive IFN signaling has profound negative impacts on human development, as demonstrated by Type I Interferonopathies, a class of genetic conditions caused by mutations that lead to elevated IFN production, and which share many phenotypes with DS [107,22,23].”
BackgroundDNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
Giordano, A. M. S., Luciani, M., Gatto, F., Abou Alezz, M., Beghè, C., Della Volpe, L., Migliara, A., Valsoni, S., Genua, M., Dzieciatkowska, M., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20211121 · Cited by 76
“Aberrant activation of cell-intrinsic pathways of NA sensing is emerging as a potential driver of several autoinflammatory and autoimmune diseases (Crow and Manel, 2015).”
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
David, C., & Frémond, M. (2022) · Cells · doi:10.3390/cells11030318 · Cited by 85
“from mainly neurologic and cutaneous manifestations [8] to articular, renal, pulmonary, and other organ involvement.”
BackgroundHall, J., Ralph, E. C., Shanker, S., Wang, H., Byrnes, L. J., Horst, R., Wong, J., Brault, A. L., Dumlao, D. S., Smith, J. F., et al. (2017) · Protein Science · doi:10.1002/pro.3304 · Cited by 81
LINE‐1 retrotransposons in healthy and diseased human brain
Suarez, N. A., Macia, Á., & Muotri, A. R. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22567 · Cited by 87
“AGS often arises when three-prime repair exonuclease 1 (TREX1) becomes mutated (Crow and Manel, 2015).”
Hosseini, S., Michaelsen-Preusse, K., Grigoryan, G., Chhatbar, C., Kalinke, U., & Korte, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107666 · Cited by 74
Nakaya, Y., Lilue, J., Stavrou, S., Moran, E. A., & Ross, S. R. (2017) · mBio · doi:10.1128/mbio.00944-17 · Cited by 74
“Abnormal cytosolic DNA accumulation associated with TREX1 mutations is thought to lead to autoimmune diseases characterized by excessive type I interferon (IFN) and cytokine production, such as Aicardi-Goutières syndrome (AGS), which results in neuronal disorders and death in childhood (3, 9–13).”
Monogenic lupus: it's all new!
Costa‐Reis, P., & Sullivan, K. E. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.008 · Cited by 87
Kozycki, C. T., Kodati, S., Huryn, L. A., Wang, H., Warner, B. M., Jani, P. H., Hammoud, D. A., Abu-Asab, M. S., Jittayasothorn, Y., Mattapallil, M. J., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2022-222629 · Cited by 84
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome
Tuttle, K. D., Waugh, K. A., Araya, P., Minter, R., Orlicky, D. J., Ludwig, M., Andrysik, Z., Burchill, M. A., Tamburini, B. A. J., Sempeck, C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108407 · Cited by 72
“Individuals affected by interferonopathies also experience delayed development, widespread autoimmunity, and cognitive impairment (Crow, 2011; Crow and Manel, 2015), raising the possibility that DS could be understood, in part, as an interferonopathy.”
BackgroundInfluentialAutoimmunity and Cancer—Two Sides of the Same Coin
Sakowska, J., Arcimowicz, Ł., Jankowiak, M., Papak, I., Markiewicz, A., Dziubek, K., Kurkowiak, M., Kote, S., Kaźmierczak-Siedlecka, K., Połom, K., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.793234 · Cited by 91
Xiong, T.-C., Wei, M., Li, F., Shi, M., Gan, H., Tang, Z., Dong, H., Liuyu, T., Gao, P., Zhong, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33671-5 · Cited by 74
“Loss-of-function mutations of TREX1 and DNase II have been reported to be highly connected with autoimmune diseases such as Aicardi-Goutieres syndrome, systemic lupus erythematosus, and retinal vasculopathy with cerebral leukodystrophy in humans 18,19 .”
Development of LB244, an Irreversible STING Antagonist
Barasa, L., Chaudhuri, S., Zhou, J. Y., Jiang, Z., Choudhary, S., Green, R. M., Wiggin, E., Cameron, M. D., Humphries, F., Fitzgerald, K. A., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c03637 · Cited by 71
DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes
Lumb, J. H., Li, Q., Popov, L. M., Ding, S., Keith, M. T., Merrill, B. D., Greenberg, H. B., Li, J. B., & Carette, J. E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.085 · Cited by 75
Terry, D. M., & Devine, S. E. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01244 · Cited by 71
“The most common cause of AGS, found in over 50% of AGS patients, is biallelic mutation of one of the three RNase H2 subunits (RNase H2A, RNase H2B, and RNase H2C) (Crow and Manel, 2015).”
BackgroundNovel TMEM173 Mutation and the Role of Disease Modifying Alleles
Keskitalo, S., Haapaniemi, E. M., Einarsdóttir, E., Rajamäki, K., Heikkilä, H., Ilander, M. M., Pöyhönen, M., Morgunova, E. Y., Hokynar, K., Lagström, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02770 · Cited by 80
“In these, increased sensing of endo- and exogenous nucleic acids leads to hyperactive Toll-like-receptors (TLRs), RNA and DNA sensors, and to an enhanced type I IFN response (2), thought to maintain the persistent self-directed immune reaction (3).”
BackgroundGanguly, D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.07.001 · Cited by 72
RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages
Pujantell, M., Riveira‐Muñoz, E., Badía, R., Castellví, M., García-Vidal, E., Sirera, G., Puig, T., Ramirez, C., Clotet, B., Esté, J. A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13580-0 · Cited by 81
Chen, S., Liu, S., Wang, J., Wu, Q., Wang, A., Guan, H., Zhang, Q. Y., Zhang, D., Wang, X., Song, H., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.018 · Cited by 78
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., O’Farrelly, C., Novelli, G., Rodríguez‐Gallego, C., Haerynck, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01030-z · Cited by 74
Stiff person syndrome and other immune-mediated movement disorders – new insights
Balint, B., & Bhatia, K. P. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000351 · Cited by 74
Interstitial Lung Disease Caused by STING-associated Vasculopathy with Onset in Infancy
Clarke, S. L. N., Pellowe, E., de Jesus, A. A., Goldbach‐Mansky, R. T., Hilliard, T. N., & Ramanan, A. V. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2102le · Cited by 68
Chang, Y.-H., & Dubnau, J. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.071 · Cited by 68
“Expression of these selfish genetic elements can cause insertional mutations, activation of inflammatory responses to both the RNAs and cDNAs that they produce, and genomic stress from DNA damage [19, 20, 45, 46].”
Contributions of maternal and fetal antiviral immunity in congenital disease
Yockey, L. J., Lucas, C., & Iwasaki, A. (2020) · Science · doi:10.1126/science.aaz1960 · Cited by 68
A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner
Rigante, D. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1280396 · Cited by 69
Molecular and physiological consequences of faulty eukaryotic ribonucleotide excision repair
Kellner, V., & Luke, B. (2020) · The EMBO Journal · doi:10.15252/embj.2019102309 · Cited by 68
“This rare early-onset autoinflammatory disease is reminiscent of both congenital viral infections and the autoimmune disease systemic lupus erythematosus (SLE), affecting brain and skin cells as well as the immune system (Crow & Manel, 2015).”
Antoniali, G., Malfatti, M. C., & Tell, G. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.06.008 · Cited by 70
Autoinflammatory Diseases: A Review
AN, J. W., Marwaha, A., & Laxer, R. M. (2024) · The Journal of Rheumatology · doi:10.3899/jrheum.2023-1209 · Cited by 77
“12 Atopy represents a reaction to harmless exogenous antigens and can be seen in numerous autoinflammatory disorders.”
Induction of the type I interferon response in neurological forms of Gaucher disease
Vitner, E. B., Farfel-Becker, T., Ferreira, N. S., Leshkowitz, D., Sharma, P., Lang, K. S., & Futerman, A. H. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0570-2 · Cited by 67
“endogenous nucleic acid products, which are subsequently sensed as non-self by the innate immune machinery [8].”
BackgroundType I IFN–related NETosis in ataxia telangiectasia and Artemis deficiency
Gul, E., Sayar, E. H., Gungor, B., Eroglu, F. K., Surucu, N., Keles, S., Guner, S. N., Findik, S., Alpdundar, E., Ayanoglu, I. C., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.030 · Cited by 67
“SAVI and several other autoinflammatory/autoimmune diseases display a unique signature of type I IFN activity, suggesting a common underlying mechanism of clinical pathologies, including systemic inflammation, skin lesions, and pulmonary disease.(1-4,27) The pathogenic mechanism(s) behind the type I IFN–inflicted tiss…”
BackgroundParra-Izquierdo, I., Castaños-Mollor, I., López, J., Gómez, C., San Román, J. A., Sánchez Crespo, M., & García-Rodríguez, C. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311504 · Cited by 68
Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus
Mustelin, T., Lood, C., & Giltiay, N. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01028 · Cited by 78
“Additional insights into themolecular mechanisms that can drive type I interferons and cause interferon-dependent human disease come from amonogenic inherited inflammatory syndrome called Aicardi-Goutières syndrome (AGS) (73–77), which, together with a few related diseases, is included in the concept of the “type I in…”
BackgroundInfluentialMarié, I. J., Chang, H.-M., & Levy, D. E. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180520 · Cited by 67
“Aberrant ISG regulation results in interferonopathies and other autoimmune diseases (Crow and Manel, 2015; Rodero and Crow, 2016).”
Background
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.